- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-9255
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effect of erythropoietin-stimulating agent on uremic inflammation ; volume:9 ; number:1 ; day:14 ; month:5 ; year:2012 ; pages:1-9 ; date:12.2012
Journal of Inflammation ; 9, Heft 1 (14.5.2012), 1-9, 12.2012
- Urheber
-
Tanaka, Yuri
- Beteiligte Personen und Organisationen
-
Joki, Nobuhiko
Hase, Hiroki
Iwasaki, Masaki
Ikeda, Masato
Ando, Ryoichi
Shinoda, Toshio
Inaguma, Daijo
Sakaguchi, Toshifumi
Komatsu, Yasuhiro
Koiwa, Fumihiko
Yamaka, Toshihiko
Shigematsu, Takashi
SpringerLink (Online service)
- DOI
-
10.1186/1476-9255-9-17
- URN
-
urn:nbn:de:1111-2016073035199
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tanaka, Yuri
- Joki, Nobuhiko
- Hase, Hiroki
- Iwasaki, Masaki
- Ikeda, Masato
- Ando, Ryoichi
- Shinoda, Toshio
- Inaguma, Daijo
- Sakaguchi, Toshifumi
- Komatsu, Yasuhiro
- Koiwa, Fumihiko
- Yamaka, Toshihiko
- Shigematsu, Takashi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effect of Erythropoietin-stimulating agent on uremic neuropathy in hemodialysis patients: a single-center open-label prospective study
Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease
Erythropoietin: a multimodal neuroprotective agent
Longitudinal Assessments of Erythropoietin-Stimulating Agent Responsiveness and the Association with Specific Clinical Outcomes in Dialysis Patients
Erythropoietin und Inflammation bei diabetischer Nephropathie
Erythropoietin und Inflammation bei diabetischer Nephropathie
Erythropoietin regulates developmental myelination in the brain stimulating postnatal oligodendrocyte maturation
Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis
Protocol of a randomized controlled trial of an erythropoietin stimulating agent decision aid for anemia treatment in kidney disease
Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: Is it feasible?
Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study
Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance
Effect of Erythropoietin-stimulating agent on uremic neuropathy in hemodialysis patients: a single-center open-label prospective study
Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease
Erythropoietin: a multimodal neuroprotective agent
Longitudinal Assessments of Erythropoietin-Stimulating Agent Responsiveness and the Association with Specific Clinical Outcomes in Dialysis Patients
Erythropoietin und Inflammation bei diabetischer Nephropathie
Erythropoietin und Inflammation bei diabetischer Nephropathie
Erythropoietin regulates developmental myelination in the brain stimulating postnatal oligodendrocyte maturation
Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis
Protocol of a randomized controlled trial of an erythropoietin stimulating agent decision aid for anemia treatment in kidney disease
Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: Is it feasible?
Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study
Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance
Effect of Erythropoietin-stimulating agent on uremic neuropathy in hemodialysis patients: a single-center open-label prospective study
Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease
Erythropoietin: a multimodal neuroprotective agent
Longitudinal Assessments of Erythropoietin-Stimulating Agent Responsiveness and the Association with Specific Clinical Outcomes in Dialysis Patients
Erythropoietin und Inflammation bei diabetischer Nephropathie
Erythropoietin und Inflammation bei diabetischer Nephropathie
Erythropoietin regulates developmental myelination in the brain stimulating postnatal oligodendrocyte maturation
Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis
Protocol of a randomized controlled trial of an erythropoietin stimulating agent decision aid for anemia treatment in kidney disease
Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: Is it feasible?
Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study